ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,555.74
-0.16%
US Tech 100
19,185.60
-0.62%
Dow Jones
40,358.09
-0.14%
Brent Oil
80.775
-0.91%
Bitcoin
65,936.38
-2.47%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. First Wave BioPharma Inc (FWBI)

  7. First Wave BioPharma Inc (FWBI) News

FWBI

First Wave BioPharma (FWBI)

First Wave BioPharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FWBI
DateTimeSourceHeadlineSymbolCompany
07/23/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
07/11/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
07/03/20242:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FWBIFirst Wave BioPharma Inc
06/24/20248:03AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FWBIFirst Wave BioPharma Inc
06/20/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
06/17/20245:23PMEdgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:FWBIFirst Wave BioPharma Inc
06/14/20245:15PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FWBIFirst Wave BioPharma Inc
06/11/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FWBIFirst Wave BioPharma Inc
06/05/20245:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
05/31/20245:25PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FWBIFirst Wave BioPharma Inc
05/30/20245:32PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FWBIFirst Wave BioPharma Inc
05/30/20245:18PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FWBIFirst Wave BioPharma Inc
05/16/20247:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
05/16/20247:00AMGlobeNewswire Inc.First Wave BioPharma Changes Name to Entero TherapeuticsNASDAQ:FWBIFirst Wave BioPharma Inc
05/14/20245:26PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FWBIFirst Wave BioPharma Inc
05/13/20245:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
05/13/20244:59PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:FWBIFirst Wave BioPharma Inc
05/10/20247:55AMGlobeNewswire Inc.First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-MarketNASDAQ:FWBIFirst Wave BioPharma Inc
05/09/20247:00AMGlobeNewswire Inc.First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness MonthNASDAQ:FWBIFirst Wave BioPharma Inc
05/08/20245:16PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FWBIFirst Wave BioPharma Inc
04/24/20247:00AMGlobeNewswire Inc.First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, NutrientsNASDAQ:FWBIFirst Wave BioPharma Inc
04/17/20247:00AMGlobeNewswire Inc.First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap ShowcaseNASDAQ:FWBIFirst Wave BioPharma Inc
04/15/20247:00AMGlobeNewswire Inc.First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders ConferenceNASDAQ:FWBIFirst Wave BioPharma Inc
03/18/20247:00AMGlobeNewswire Inc.First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) ConferenceNASDAQ:FWBIFirst Wave BioPharma Inc
03/14/20246:00AMGlobeNewswire Inc.First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical PipelineNASDAQ:FWBIFirst Wave BioPharma Inc
03/05/20245:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
03/05/20247:00AMGlobeNewswire Inc.First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth ConferenceNASDAQ:FWBIFirst Wave BioPharma Inc
03/04/20245:29PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:FWBIFirst Wave BioPharma Inc
03/04/20248:00AMGlobeNewswire Inc.First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct OfferingNASDAQ:FWBIFirst Wave BioPharma Inc
02/13/20247:00AMGlobeNewswire Inc.First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024NASDAQ:FWBIFirst Wave BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:FWBI

Your Recent History

BIT
UIE859
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved